161 related articles for article (PubMed ID: 12374046)
1. [Cyclosporin A in atopic dermatitis].
Cordero Miranda MA; Casas Becerra B; Reyes Ruiz NI; Avila Castañón L; del Río Navarro BE; Sienra Monge JJ
Rev Alerg Mex; 2002; 49(4):129-34. PubMed ID: 12374046
[TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis.
Berth-Jones J; Graham-Brown RA; Marks R; Camp RD; English JS; Freeman K; Holden CA; Rogers SC; Oliwiecki S; Friedmann PS; Lewis-Jones MS; Archer CB; Adriaans B; Douglas WS; Allen BR
Br J Dermatol; 1997 Jan; 136(1):76-81. PubMed ID: 9039299
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporin is safe and effective in severe atopic dermatitis of childhood. Report of three cases.
Leonardi S; Marchese G; Rotolo N; Miraglia Del Giudice M; La Rosa M
Minerva Pediatr; 2004 Apr; 56(2):231-7. PubMed ID: 15249910
[TBL] [Abstract][Full Text] [Related]
4. Mechanism underlying the effect of combined therapy using glucosamine and low-dose cyclosporine A on the development of atopic dermatitis-like skin lesions in NC/Nga mice.
Kim CH; Choi YS; Cheong KA; Lee AY
Int Immunopharmacol; 2013 Feb; 15(2):424-32. PubMed ID: 23352844
[TBL] [Abstract][Full Text] [Related]
5. Monitoring trough levels in cyclosporine for atopic dermatitis: A systematic review.
Blake SC; Murrell DF
Pediatr Dermatol; 2019 Nov; 36(6):843-853. PubMed ID: 31566785
[TBL] [Abstract][Full Text] [Related]
6. Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study.
Pacor ML; Di Lorenzo G; Martinelli N; Mansueto P; Rini GB; Corrocher R
Clin Exp Allergy; 2004 Apr; 34(4):639-45. PubMed ID: 15080819
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporin for atopic dermatitis in children.
Harper JI; Berth-Jones J; Camp RD; Dillon MJ; Finlay AY; Holden CA; O'Sullivan D; Veys PA
Dermatology; 2001; 203(1):3-6. PubMed ID: 11549791
[TBL] [Abstract][Full Text] [Related]
8. Consensus on the use of cyclosporine in dermatological practice. Italian Consensus Conference.
Altomare G; Ayala F; Bardazzi F; Bellia G; Chimenti S; Colombo D; Flori ML; Girolomoni G; Micali G; Parodi A; Peris K; Vena GA;
G Ital Dermatol Venereol; 2014 Oct; 149(5):607-25. PubMed ID: 25213388
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine treatment decreases the percentage of cutaneous lymphocyte antigen (CLA)(+)CD4(+) T cells in children with severe atopic dermatitis.
Lee SY; Shim JY; Kim JH; Kim BS; Seo HJ; Choi SO; Jang SO; Hong SJ
Allergy; 2004 Oct; 59(10):1129-30. PubMed ID: 15355478
[No Abstract] [Full Text] [Related]
10. Efficacy and safety of long-term treatment with cyclosporin A for atopic dermatitis.
Hijnen DJ; ten Berge O; Timmer-de Mik L; Bruijnzeel-Koomen CA; de Bruin-Weller MS
J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):85-9. PubMed ID: 17207173
[TBL] [Abstract][Full Text] [Related]
11. Low-Dose Cyclosporine A in the Treatment of Severe Atopic Dermatitis Complicated by Chronic Hepatitis C Virus Infection.
Gnarra M; De Simone C; Garcovich M; Garcovich S
Pediatr Dermatol; 2017 May; 34(3):374-376. PubMed ID: 28382768
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporin in atopic dermatitis: review of the literature and outline of a Belgian consensus.
Naeyaert JM; Lachapelle JM; Degreef H; de la Brassinne M; Heenen M; Lambert J
Dermatology; 1999; 198(2):145-52. PubMed ID: 10325461
[TBL] [Abstract][Full Text] [Related]
13. Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial.
Haeck IM; Knol MJ; Ten Berge O; van Velsen SG; de Bruin-Weller MS; Bruijnzeel-Koomen CA
J Am Acad Dermatol; 2011 Jun; 64(6):1074-84. PubMed ID: 21458107
[TBL] [Abstract][Full Text] [Related]
14. Macrolactam immunomodulators for topical treatment of inflammatory skin diseases.
Bornhövd E; Burgdorf WH; Wollenberg A
J Am Acad Dermatol; 2001 Nov; 45(5):736-43. PubMed ID: 11606925
[TBL] [Abstract][Full Text] [Related]
15. Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis.
Prescrire Int; 2004 Dec; 13(74):209-12. PubMed ID: 15599989
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine in severe childhood atopic dermatitis: a multicenter study.
Berth-Jones J; Finlay AY; Zaki I; Tan B; Goodyear H; Lewis-Jones S; Cork MJ; Bleehen SS; Salek MS; Allen BR; Smith S; Graham-Brown RA
J Am Acad Dermatol; 1996 Jun; 34(6):1016-21. PubMed ID: 8647967
[TBL] [Abstract][Full Text] [Related]
17. Retrospective review of relapse after systemic cyclosporine in children with atopic dermatitis.
Sibbald C; Pope E; Ho N; Weinstein M
Pediatr Dermatol; 2015; 32(1):36-40. PubMed ID: 25059452
[TBL] [Abstract][Full Text] [Related]
18. [Safety and efficacy of treatment for severe atopic dermatitis with cyclosporin A and transfer factor].
Cordero Miranda MA; Flores Sandoval G; Orea Solano M; Estrada Parra S; Serrano Miranda E
Rev Alerg Mex; 1999; 46(2):49-57. PubMed ID: 10391070
[TBL] [Abstract][Full Text] [Related]
19. Calcineurin inhibitors: 40 years later, can't live without ..
Azzi JR; Sayegh MH; Mallat SG
J Immunol; 2013 Dec; 191(12):5785-91. PubMed ID: 24319282
[TBL] [Abstract][Full Text] [Related]
20. A body-weight-independent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of life.
Czech W; Bräutigam M; Weidinger G; Schöpf E
J Am Acad Dermatol; 2000 Apr; 42(4):653-9. PubMed ID: 10727313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
